Robert R. Luedtke

3.4k total citations
99 papers, 2.9k citations indexed

About

Robert R. Luedtke is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Computational Theory and Mathematics. According to data from OpenAlex, Robert R. Luedtke has authored 99 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 75 papers in Cellular and Molecular Neuroscience and 7 papers in Computational Theory and Mathematics. Recurrent topics in Robert R. Luedtke's work include Receptor Mechanisms and Signaling (71 papers), Neurotransmitter Receptor Influence on Behavior (55 papers) and Pharmacological Receptor Mechanisms and Effects (28 papers). Robert R. Luedtke is often cited by papers focused on Receptor Mechanisms and Signaling (71 papers), Neurotransmitter Receptor Influence on Behavior (55 papers) and Pharmacological Receptor Mechanisms and Effects (28 papers). Robert R. Luedtke collaborates with scholars based in United States, France and Sweden. Robert R. Luedtke's co-authors include Robert H. Mach, Michelle Taylor, Amy Hauck Newman, Peter Grundt, Suzy A. Griffin, Jinbin Xu, Perry B. Molinoff, Jianjing Cao, Suwanna Vangveravong and Zhude Tu and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and PLoS ONE.

In The Last Decade

Robert R. Luedtke

95 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert R. Luedtke United States 31 2.1k 1.9k 260 244 231 99 2.9k
David E. Nichols United States 20 1.6k 0.8× 1.7k 0.9× 107 0.4× 130 0.5× 341 1.5× 50 2.5k
Antoni Cortés Spain 37 2.4k 1.1× 1.9k 1.0× 215 0.8× 124 0.5× 98 0.4× 71 3.6k
Cyril Goudet France 34 2.3k 1.1× 2.1k 1.1× 118 0.5× 90 0.4× 161 0.7× 68 3.3k
Juan F. López‐Giménez Spain 24 1.6k 0.8× 2.0k 1.0× 113 0.4× 52 0.2× 186 0.8× 39 2.7k
Alice L. Rodriguez United States 32 2.1k 1.0× 1.9k 1.0× 75 0.3× 284 1.2× 610 2.6× 117 3.2k
Ram K. Mishra Canada 34 2.0k 1.0× 1.9k 1.0× 296 1.1× 74 0.3× 452 2.0× 162 3.6k
Thomas M. Bridges United States 29 2.4k 1.2× 2.0k 1.0× 65 0.3× 278 1.1× 356 1.5× 102 3.1k
Sylvie Claeysen France 33 1.7k 0.8× 1.5k 0.8× 107 0.4× 335 1.4× 223 1.0× 62 3.1k
Stephan Urwyler Switzerland 25 1.7k 0.8× 2.2k 1.1× 101 0.4× 108 0.4× 182 0.8× 55 2.8k
Xavier Langlois Belgium 38 2.1k 1.0× 2.3k 1.2× 223 0.9× 110 0.5× 212 0.9× 104 4.2k

Countries citing papers authored by Robert R. Luedtke

Since Specialization
Citations

This map shows the geographic impact of Robert R. Luedtke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert R. Luedtke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert R. Luedtke more than expected).

Fields of papers citing papers by Robert R. Luedtke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert R. Luedtke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert R. Luedtke. The network helps show where Robert R. Luedtke may publish in the future.

Co-authorship network of co-authors of Robert R. Luedtke

This figure shows the co-authorship network connecting the top 25 collaborators of Robert R. Luedtke. A scholar is included among the top collaborators of Robert R. Luedtke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert R. Luedtke. Robert R. Luedtke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsieh, Chia‐Ju, Aladdin Riad, Ji Youn Lee, et al.. (2021). Interaction of Ligands for PET with the Dopamine D3 Receptor: In Silico and In Vitro Methods. Biomolecules. 11(4). 529–529. 6 indexed citations
2.
Zeberg, Hugo, Tomasz Maciej Stępniewski, R. Benjamin Free, et al.. (2020). Ligand with Two Modes of Interaction with the Dopamine D2 Receptor–An Induced-Fit Mechanism of Insurmountable Antagonism. ACS Chemical Neuroscience. 11(19). 3130–3143. 8 indexed citations
3.
Reilly, Sean W., Aladdin Riad, Chia‐Ju Hsieh, et al.. (2019). Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D3 Receptor (D3R) Ligand Promiscuity across Highly Conserved Aminergic G-Protein-Coupled Receptors (GPCRs). Journal of Medicinal Chemistry. 62(10). 5132–5147. 15 indexed citations
4.
Rangel‐Barajas, Claudia, Ana María Estrada‐Sánchez, Scott J. Barton, Robert R. Luedtke, & George V. Rebec. (2016). Dysregulated corticostriatal activity in open-field behavior and the head-twitch response induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine. Neuropharmacology. 113(Pt A). 502–510. 7 indexed citations
5.
6.
7.
Li, Aixiao, Qi Wang, Shihong Li, et al.. (2013). Evaluation of N-phenyl homopiperazine analogs as potential dopamine D3 receptor selective ligands. Bioorganic & Medicinal Chemistry. 21(11). 2988–2998. 13 indexed citations
8.
Luedtke, Robert R., Qi Wang, Suzy A. Griffin, et al.. (2012). Comparison of the Binding and Functional Properties of Two Structurally Different D2 Dopamine Receptor Subtype Selective Compounds. ACS Chemical Neuroscience. 3(12). 1050–1062. 26 indexed citations
9.
Gould, Robert W., Ashwini K. Banala, Peter Grundt, et al.. (2011). Influence of Cocaine History on the Behavioral Effects of Dopamine D3 Receptor-Selective Compounds in Monkeys. Neuropsychopharmacology. 36(5). 1104–1113. 18 indexed citations
10.
Kumar, Rakesh, et al.. (2010). Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on l-dopa dependent animal involuntary movements in rats. Neuropharmacology. 60(2-3). 284–294. 18 indexed citations
11.
12.
Grundt, Peter, et al.. (2006). Analogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SAR. Bioorganic & Medicinal Chemistry Letters. 17(3). 745–749. 35 indexed citations
13.
14.
Luedtke, Robert R. & Robert H. Mach. (2003). Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric Disorders. Current Pharmaceutical Design. 9(8). 643–671. 75 indexed citations
15.
Huang, Yun‐Sheng, et al.. (2001). Synthesis of 2-(2,3-dimethoxyphenyl)-4-(aminomethyl)imidazole analogues and their binding affinities for dopamine D2 and D3 receptors. Bioorganic & Medicinal Chemistry. 9(12). 3113–3122. 13 indexed citations
16.
Hammond, Philip S., et al.. (1999). Synthesis, in vitro dopamine D2 and D3 receptor binding and quantitative structure-activity studies on substituted 2,3-dimethoxy-N-(1- benzyl-4-piperidinyl)benzamides and related compounds. Medicinal Chemistry Research. 9(1). 35–49. 4 indexed citations
17.
Mach, Robert H., Michael A. Nader, Richard L. Ehrenkaufer, et al.. (1996). Comparison of two fluorine-18 labeled benzamide derivatives that bind reversibly to dopamine D2 receptors: In vitro binding studies and positron emission tomography. Synapse. 24(4). 322–333. 27 indexed citations
18.
Essman, William D., Robert R. Luedtke, Paul McGonigle, & Irwin Lucki. (1995). Variations in the behavioral responses to apomorphine in different strains of rats. Behavioural Pharmacology. 6(1). 4???15–4???15. 15 indexed citations
19.
Boundy, Virginia A., Robert R. Luedtke, & Perry B. Molinoff. (1993). Development of Polyclonal Anti‐D2 Dopamine Receptor Antibodies to Fusion Proteins: Inhibition of D2 Receptor–G Protein Interaction. Journal of Neurochemistry. 60(6). 2181–2191. 14 indexed citations
20.
Ivins, Kathryn J., Robert R. Luedtke, R P Artymyshyn, & Perry B. Molinoff. (1991). Regulation of dopamine D2 receptors in a novel cell line (SUP1).. Molecular Pharmacology. 39(4). 531–539. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David E. Nichols Breakdown of academic impact, for papers by Antoni Cortés Breakdown of academic impact, for papers by Cyril Goudet Breakdown of academic impact, for papers by Juan F. López‐Giménez Breakdown of academic impact, for papers by Alice L. Rodriguez Breakdown of academic impact, for papers by Ram K. Mishra Breakdown of academic impact, for papers by Thomas M. Bridges Breakdown of academic impact, for papers by Sylvie Claeysen Breakdown of academic impact, for papers by Stephan Urwyler Breakdown of academic impact, for papers by Xavier Langlois
Rankless by CCL
2026